When you hear the word epilepsy, what comes to mind? For many, it rsquo;s a vague image of someone having a seizure ndash; ...

Neuromod Devices has secured €10m ($10.8m) in equity financing to broaden the reach of Lenire, its treatment device.

Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...

The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...

Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving a rare ...

New Health Canada Approval Allows Spark Biomedical to Offer Drug-Free Opioid Withdrawal Relief Across Canada.Dallas, TX, ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

The global pain management devices market is set to experience robust growth, with sales projected to rise from USD 3,019.8 ...

The global extracorporeal membrane oxygenation machine market is on a growth trajectory, with revenue anticipated to reach ...